ARCHIVES

In Brief: O’Conor Now Top Prospect If Rauscher Leaves; Flood Gives NCI Increase Of Only $11 Million

This article is from The Cancer Letter archive.

Vol. 02 No. 20 | May 14, 1976

Download PDF Visit The Full Archive

Related Articles

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Parkinson Heads Oncology At Amgen

May 2, 2003

NCI-Approved Clinical Trials

October 27, 2006

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

HPV Can Affect Response To Radiation Therapies

September 28, 2012